Natera, Inc. (NTRA)

USD 146.95

(2.56%)

Operating Expenses Summary of Natera, Inc.

  • Natera, Inc.'s latest annual operating expenses in 2023 was 938.98 Million USD , up 3.46% from previous year.
  • Natera, Inc.'s latest quarterly operating expenses in 2024 Q1 was 282.91 Million USD , up 15.76% from previous quarter.
  • Natera, Inc. reported a annual operating expenses of 905 Million USD in annual operating expenses 2022, up 16.74% from previous year.
  • Natera, Inc. reported a annual operating expenses of 775.24 Million USD in annual operating expenses 2021, up 92.05% from previous year.
  • Natera, Inc. reported a quarterly operating expenses of 287.07 Million USD for 2024 Q2, up 1.47% from previous quarter.
  • Natera, Inc. reported a quarterly operating expenses of 230.68 Million USD for 2023 Q2, down -0.54% from previous quarter.

Annual Operating Expenses Chart of Natera, Inc. (2023 - 2012)

Historical Annual Operating Expenses of Natera, Inc. (2023 - 2012)

Year Operating Expenses Operating Expenses Growth
2023 938.98 Million USD 3.46%
2022 905 Million USD 16.74%
2021 775.24 Million USD 92.05%
2020 403.66 Million USD 56.74%
2019 257.53 Million USD 24.88%
2018 206.22 Million USD 0.42%
2017 205.37 Million USD 15.38%
2016 177.98 Million USD 29.59%
2015 137.34 Million USD 71.2%
2014 80.22 Million USD 85.87%
2013 43.16 Million USD 93.49%
2012 22.3 Million USD 0.0%

Peer Operating Expenses Comparison of Natera, Inc.

Name Operating Expenses Operating Expenses Difference
Aclaris Therapeutics, Inc. 110.52 Million USD -749.568%
Applied DNA Sciences, Inc. 16.48 Million USD -5595.401%
Aspira Women's Health Inc. 24.11 Million USD -3793.941%
Biodesix, Inc. 77.41 Million USD -1112.861%
BioNexus Gene Lab Corp. 3.92 Million USD -23834.856%
bioAffinity Technologies, Inc. 8.76 Million USD -10613.084%
bioAffinity Technologies, Inc. 8.76 Million USD -10613.084%
Bionano Genomics, Inc. 148.99 Million USD -530.221%
CareDx, Inc 277.76 Million USD -238.046%
Check-Cap Ltd. 19.28 Million USD -4768.487%
Castle Biosciences, Inc. 242.78 Million USD -286.759%
DarioHealth Corp. 62.17 Million USD -1410.278%
Exact Sciences Corporation 2.06 Billion USD 54.43%
Fulgent Genetics, Inc. 171.9 Million USD -446.22%
Guardant Health, Inc. 901.62 Million USD -4.144%
ICON Public Limited Company 755.64 Million USD -24.263%
IDEXX Laboratories, Inc. 1.09 Billion USD 14.079%
Illumina, Inc. 3.81 Billion USD 75.374%
Intelligent Bio Solutions Inc. 11.7 Million USD -7919.481%
iSpecimen Inc. 16.27 Million USD -5668.69%
Standard BioTools Inc. 113.48 Million USD -727.38%
MDxHealth SA 71.25 Million USD -1217.763%
23andMe Holding Co. 420.73 Million USD -123.178%
Medpace Holdings, Inc. 187.68 Million USD -400.312%
Myriad Genetics, Inc. 600.1 Million USD -56.471%
Mainz Biomed B.V. 27.15 Million USD -3357.955%
ENDRA Life Sciences Inc. 10.52 Million USD -8825.089%
NeoGenomics, Inc. 341.25 Million USD -175.159%
Neogen Corporation 405.23 Million USD -131.713%
Inotiv, Inc. 246.9 Million USD -280.305%
OpGen, Inc. 30.65 Million USD -2962.777%
OPKO Health, Inc. 574.68 Million USD -63.391%
Psychemedics Corporation 11.33 Million USD -8184.674%
Prenetics Global Limited 60.73 Million USD -1445.995%
Prenetics Global Limited 60.73 Million USD -1445.995%
Precipio, Inc. 13.63 Million USD -6785.064%
Personalis, Inc. 128.14 Million USD -632.758%
RadNet, Inc. 268.87 Million USD -249.222%
Sera Prognostics, Inc. 39.91 Million USD -2252.344%
Sotera Health Company 300.46 Million USD -212.51%
Neuronetics, Inc. 82.25 Million USD -1041.498%
Star Equity Holdings, Inc. 16.27 Million USD -5670.557%
Star Equity Holdings, Inc. 16.27 Million USD -5670.557%
Trinity Biotech plc 46.49 Million USD -1919.54%
T2 Biosystems, Inc. 41.49 Million USD -2162.942%
Twist Bioscience Corporation 354.18 Million USD -165.115%
Exagen Inc. 52.29 Million USD -1695.623%